On September 9, 2025, Citius Oncology, Inc. announced a registered direct offering of 5,142,858 shares and warrants at $1.75 per unit, expected to raise approximately $7.48 million. The offering closed on September 10, 2025, with investor restrictions for 65 days on new equity issuance.